NCT05319912View on ClinicalTrials.gov

A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 7, 2014

Primary Completion Date

May 29, 2014

Study Completion Date

May 29, 2014

Conditions
Healthy
Interventions
DRUG

ALXN1840 Enteric-coated Tablet

ALXN1840 (60 milligrams) was administered orally as EC tablets at Hour 0 on Day 1.

DRUG

ALXN1840 Non-coated Capsule

ALXN1840 (60 milligrams) was administered orally as non-coated capsules at Hour 0 on Day 1.

DRUG

Omeprazole

Omeprazole (20 milligrams) was administered orally as a delayed-release capsule in the morning of Days -5 to -1 and at Hour -1 on Day 1.

Trial Locations (1)

68502

Clinical Trial Site, Lincoln

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY

NCT05319912 - A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults | Biotech Hunter | Biotech Hunter